Literature DB >> 22899753

Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy.

Yoshihiro Wakabayashi1, Yoshihiko Usui, Yoko Okunuki, Shunichiro Ueda, Keisuke Kimura, Daisuke Muramatsu, Takeshi Kezuka, Hiroshi Goto.   

Abstract

PURPOSE: To investigate whether vitreous and aqueous humor concentrations of vascular endothelial growth factor (VEGF) predict postoperative complications after vitrectomy for proliferative diabetic retinopathy (PDR).
METHODS: Sixty eyes of 52 patients with PDR who underwent vitrectomy were enrolled. Vitreous and aqueous humor were obtained from eyes with PDR during primary vitrectomy and the levels of VEGF were measured using a commercial flow cytometer. Patients were followed for more than 6 months after surgery. Demographic data and both intraoperative and postoperative findings were recorded. The relationship between VEGF levels in ocular fluids and the main postoperative complications of early vitreous hemorrhage (VH) and neovascular glaucoma (NVG) occurring during follow-up was analyzed. Logistic regression analyses were performed to examine risk factors related to postoperative complications.
RESULTS: Early VH occurred in 25%, and NVG occurred in 8% of 60 eyes. The vitreous levels of VEGF were significantly higher (P = 0.015) in eyes with early VH than in those without. The aqueous humor and vitreous levels of VEGF were significantly higher (P = 0.005 and P = 0.001, respectively) in eyes with NVG than in those without. Axial length was significantly shorter in eyes with early VH than in those without (P = 0.028). Multivariate logistic regression analysis showed that the higher vitreous VEGF level was associated with a risk of early VH after vitrectomy for PDR (odds ratio, 5.1; P = 0.020).
CONCLUSIONS: High intraocular VEGF level at the time of primary vitrectomy in patients with PDR was identified as a significant risk factor for postoperative early VH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899753     DOI: 10.1167/iovs.12-10367

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  18 in total

Review 1.  Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Ryan H Mason; Samuel A Minaker; Gabriela Lahaie Luna; Priya Bapat; Armin Farahvash; Anubhav Garg; Nishaant Bhambra; Rajeev H Muni
Journal:  Eye (Lond)       Date:  2022-06-07       Impact factor: 4.456

2.  Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma.

Authors:  Anatoly Kuzmin; Dmitry Lipatov; Timofei Chistyakov; Olga Smirnova; Margarita Arbuzova; Alexander Ilin; Marina Shestakova; Ivan Dedov
Journal:  Ophthalmol Ther       Date:  2013-06-01

3.  Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.

Authors:  V V Chernykh; E V Varvarinsky; E V Smirnov; D V Chernykh; Alexander N Trunov
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

4.  Vitreous and plasma VEGF levels as predictive factors in the progression of proliferative diabetic retinopathy after vitrectomy.

Authors:  Jiaxing Wang; Song Chen; Feng Jiang; Caiyun You; Chunjie Mao; Jinguo Yu; Jindong Han; Zhuhong Zhang; Hua Yan
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

5.  Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Masashi Sakamoto; Ryuya Hashimoto; Izumi Yoshida; Makoto Ubuka; Takatoshi Maeno
Journal:  Clin Ophthalmol       Date:  2018-11-14

6.  Vitreous concentrations of vascular endothelial growth factor as a potential biomarker for postoperative complications following pars plana vitrectomy.

Authors:  Faruk Nisic; Nina Jovanovic; Milka Mavija; Emina Alimanovic-Halilovic; Aida Nisic; Orhan Lepara; Adem Cemerlic
Journal:  Arch Med Sci       Date:  2018-02-02       Impact factor: 3.318

7.  Evaluation of barriers between anterior and posterior compartments during Nd:YAG capsulotomy in diabetic patients.

Authors:  Pelin Ozyol; Erhan Ozyol
Journal:  Clin Ophthalmol       Date:  2014-03-03

8.  Intravitreal Ranibizumab Injection as an Adjuvant in the Treatment of Neovascular Glaucoma Accompanied by Vitreous Hemorrhage after Diabetic Vitrectomy.

Authors:  Xi Shen; Yanwei Chen; Yanuo Wang; Lu Yang; Yisheng Zhong
Journal:  J Ophthalmol       Date:  2016-05-16       Impact factor: 1.909

9.  Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.

Authors:  Xiu-Juan Li; Xiao-Peng Yang; Qiu-Ming Li; Yu-Ying Wang; Xiao-Bei Lyu
Journal:  Chin Med J (Engl)       Date:  2015-08-05       Impact factor: 2.628

10.  Outcomes of 23-Gauge Vitrectomy Combined with Phacoemulsification, Panretinal Photocoagulation, and Trabeculectomy without Use of Anti-VEGF Agents for Neovascular Glaucoma with Vitreous Hemorrhage.

Authors:  Hua Yan
Journal:  J Ophthalmol       Date:  2016-01-17       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.